NEW YORK – Novo Nordisk has teamed up with Health Innovation Technology Lab to launch the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk. “This is the first time we are focusing the World Cup on a single disease—diabetes—and specific area of technology,” said Stan Kachnowski, HITLAB chair, in a statement. “The need couldn’t be greater, and I am sure ideas are in development all around the globe. Together with Novo Nordisk, we want to accelerate the rate of breakthrough technologies that will help millions of people living with diabetes worldwide.” Winning entries should demonstrate an ability to effectively address the unmet needs of the type 2 diabetes community. Projects must show how the voice-activated technology solution differs from current practice, technology, or services available to consumers, and they must provide a sound, sustainable business model. HITLAB has hosted the challenge since 2006. Last year, 74 teams from 14 countries presented technology innovations. Past winners have since raised over $50 million in follow-on investment funding. Prizes totaling $75,000 will be awarded.
You are here: / / Novo Nordisk, HITLAB seeking health tech innovation for World Cup Challenge